JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

Astrana Health Inc

Open

BrancheGesundheitswesen

32.91 -3.83

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

32.51

Max

34.12

Schlüsselkennzahlen

By Trading Economics

Einkommen

4M

10M

Verkäufe

34M

655M

KGV

Branchendurchschnitt

63.442

37.461

Gewinnspanne

1.56

Angestellte

1,900

EBITDA

7.4M

31M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+28.36% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

513M

1.5B

Vorheriger Eröffnungskurs

36.74

Vorheriger Schlusskurs

32.91

Nachrichtenstimmung

By Acuity

50%

50%

154 / 373 Ranking in Healthcare

Astrana Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Okt. 2025, 23:50 UTC

Heiße Aktien

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28. Okt. 2025, 23:25 UTC

Ergebnisse

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28. Okt. 2025, 23:18 UTC

Ergebnisse

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28. Okt. 2025, 22:20 UTC

Ergebnisse

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28. Okt. 2025, 22:13 UTC

Ergebnisse

Wal-Mart de Mexico Net Profit Falls in 3Q

28. Okt. 2025, 21:38 UTC

Ergebnisse

Correction to Visa Sales Jump Article

28. Okt. 2025, 21:17 UTC

Ergebnisse

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28. Okt. 2025, 21:07 UTC

Ergebnisse

Visa Sales Jump as Consumers Keep Spending -- Update

28. Okt. 2025, 21:02 UTC

Ergebnisse

Mondelez Tempers Outlook as Costs Rise

28. Okt. 2025, 23:51 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28. Okt. 2025, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28. Okt. 2025, 23:02 UTC

Ergebnisse

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28. Okt. 2025, 23:01 UTC

Ergebnisse

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28. Okt. 2025, 22:46 UTC

Ergebnisse

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28. Okt. 2025, 22:45 UTC

Ergebnisse

SK Hynix 3Q Net KRW12.6T >000660.SE

28. Okt. 2025, 22:44 UTC

Ergebnisse

SK Hynix 3Q Rev KRW24.44T >000660.SE

28. Okt. 2025, 22:43 UTC

Ergebnisse

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28. Okt. 2025, 22:42 UTC

Ergebnisse

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28. Okt. 2025, 22:40 UTC

Ergebnisse

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28. Okt. 2025, 22:40 UTC

Ergebnisse

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28. Okt. 2025, 22:20 UTC

Ergebnisse

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28. Okt. 2025, 22:02 UTC

Ergebnisse

Review & Preview: Earnings Extravaganza -- Barrons.com

28. Okt. 2025, 21:42 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

28. Okt. 2025, 21:42 UTC

Market Talk
Ergebnisse

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28. Okt. 2025, 21:20 UTC

Ergebnisse

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28. Okt. 2025, 21:19 UTC

Ergebnisse

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28. Okt. 2025, 21:18 UTC

Ergebnisse

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Peer-Vergleich

Kursveränderung

Astrana Health Inc Prognose

Kursziel

By TipRanks

28.36% Vorteil

12-Monats-Prognose

Durchschnitt 43.5 USD  28.36%

Hoch 50 USD

Tief 36 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Astrana Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

6

Buy

1

Halten

0

Sell

Stimmung

By Acuity

154 / 373 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Astrana Health Inc

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
help-icon Live chat